For example, in acute and chronic asthma, intranasal infusion of BM‐MSC‐CM can reduce the levels of inflammatory cytokines IL‐4 and IL‐13 in the lungs and increase the level of IL‐10.198. This evidence concerns the gene IL13 and chronic asthma.